Request Demo
Last update 08 May 2025
Chengdu Huajian Future Technology Co., Ltd
Last update 08 May 2025
Overview
Tags
Neoplasms
Digestive System Disorders
Skin and Musculoskeletal Diseases
Small molecule drug
Chemical drugs
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20233611
评价 HJ787 软膏单次给药和多次给药在健康受试者中的安全性、耐受性及药代动力学的 I 期临床研究
[Translation] Phase I clinical study to evaluate the safety, tolerability and pharmacokinetics of single and repeated administration of HJ787 ointment in healthy subjects
CTR20231351
评价 HJ891 用于非小细胞肺癌的抗肿瘤疗效的单臂、开放 IIb 期临床研究
[Translation] A single-arm, open-label phase IIb clinical study to evaluate the anti-tumor efficacy of HJ891 in non-small cell lung cancer
CTR20191064
HJ197 胶囊治疗晚期肝细胞癌患者的单臂、开放、安全性、 耐受性、药代动力学及抗肿瘤疗效的 I 期临床研究
[Translation] A single-arm, open-label, phase I clinical study on the safety, tolerability, pharmacokinetics and antitumor efficacy of HJ197 capsule in the treatment of patients with advanced hepatocellular carcinoma
100 Clinical Results associated with Chengdu Huajian Future Technology Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Chengdu Huajian Future Technology Co., Ltd
Login to view more data
100 Translational Medicine associated with Chengdu Huajian Future Technology Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 18 May 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
5
Preclinical
Phase 1 Clinical
1
3
Phase 2 Clinical
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free